Pharmacosynthetics: Reimagining the pharmacogenetic approach
about
Therapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and OptogeneticsSynthetic biology for pharmaceutical drug discoveryNeuroanatomy goes viral!DREADDs: novel tools for drug discovery and developmentTreating Parkinson's disease in the 21st century: can stem cell transplantation compete?Sonogenetics is a non-invasive approach to activating neurons in Caenorhabditis elegansConnections of the juxtaventromedial region of the lateral hypothalamic area in the male ratThe bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice.An estrogen-responsive module in the ventromedial hypothalamus selectively drives sex-specific activity in females.The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.The Regulation of Immunological Processes by Peripheral Neurons in Homeostasis and DiseaseDREADD-Induced Silencing of the Medial Olfactory Tubercle Disrupts the Preference of Female Mice for Opposite-Sex Chemosignals(1,2,3).Chemogenetic Inactivation of Dorsal Anterior Cingulate Cortex Neurons Disrupts Attentional Behavior in Mouse.Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling.DREADDS: Use and application in behavioral neuroscienceSelective Manipulation of Neural CircuitsBasal Forebrain Cholinergic Neurons Primarily Contribute to Inhibition of Electroencephalogram Delta Activity, Rather Than Inducing Behavioral Wakefulness in MiceControlling feeding behavior by chemical or gene-directed targeting in the brain: what's so spatial about our methods?Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?Activation of the Hypoglossal to Tongue Musculature Motor Pathway by Remote Control.New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's diseaseDopaminergic modulation of striatal networks in health and Parkinson's disease.Memory Retention Involves the Ventrolateral Orbitofrontal Cortex: Comparison with the Basolateral Amygdala.Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates.Chemogenetic Modulation of G Protein-Coupled Receptor Signalling in Visual Attention Research.DREADD: a chemogenetic GPCR signaling platformPatterns across multiple memories are identified over time.Injection parameters and virus dependent choice of promoters to improve neuron targeting in the nonhuman primate brain.Striatal adenosine A2A receptor neurons control active-period sleep via parvalbumin neurons in external globus pallidus.The use of chemogenetics in behavioural neuroscience: Receptor variants, targeting approaches, and caveats.Orexins Mediate Sex Differences in the Stress Response and in Cognitive Flexibility.Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics.Low Dose Medicine: theoretical background and scientific evidence.Reduced Orexin System Function Contributes to Resilience to Repeated Social Stress.Multisite Electrophysiology Recordings in Mice to Study Cross-Regional Communication During Anxiety.
P2860
Q26765373-CC3F7F65-61A4-4FEE-8FD9-298FEEC57D66Q26775582-CDC03C0F-0763-44CF-8FEA-5DB756A0FC1BQ26802140-F3C10525-9632-444E-A326-E7843616CD43Q26995396-B1A216E1-E893-4513-A86E-4365659CE644Q27024152-85425BE5-20BA-49A5-918C-39A2592131FAQ30402051-587A067A-4E69-400A-82BC-456912D880BFQ30409447-BC0A7F37-07FD-4943-AC2F-67082024381EQ30685451-1D258B82-36FD-4BA1-8A3C-CA2F8C856A6EQ35074170-1EC16D13-F271-4C81-9D9A-6539DBBBB80EQ35201554-390CEBD1-653E-48AC-99F6-702C0E96CFB4Q36119050-1D3AF662-536C-4D57-801E-EA15A09EE2E1Q36154355-795E7D53-14C6-4AE6-9498-C20F6F9E7877Q36565626-7DDEF161-7D41-494B-8307-58EE004729E7Q36607377-F96E2EBC-6FAA-4F0A-BE1E-C5B730886DF0Q36689339-41FE685E-8E3A-48C4-9F45-19394E147C78Q36775253-39974795-69F8-4CB9-B92D-656D931E7BDDQ37006324-CAE41C62-31B8-4038-AC5C-90CBBB5ADBBFQ37400059-59B70D7C-F764-412F-8682-FB2DC7D591B3Q37670707-08598288-3BA0-4346-90B1-4DA5F5E89FC5Q37739839-193A7C92-EFEC-4047-A30E-15925DDA66F8Q38075712-FE744AFE-D255-4198-A6DC-DD9BA9FD53C4Q38233462-716DDF04-2235-429A-834D-7873331AA012Q38664588-99A848E9-BCD6-4CA7-8ABB-EBC568EFD1DEQ38737932-B3E84D3E-4915-46E1-AC6F-CC3E9F39EBB8Q39151291-557BEFF4-B825-4FD7-B48A-75F0EADC7840Q39369789-BFA0B2DB-1435-48C7-B6D9-B5E9E1E6D1A0Q42161663-83D51C93-D98F-4685-BF9C-9ABB539B3AA9Q42215657-3FCA5C0A-798C-4938-93F4-75E64D97DF21Q42244482-64A29C81-A48F-41F8-9243-5473AFB47A00Q42637831-9A42914A-E3BA-41AB-A372-0DD6BA581E56Q47553027-AC916BB3-D652-41B0-9D3A-63D6F660F9C5Q47919542-41C9488A-2D53-41E9-91E8-8FC56E6F74CBQ48096641-15062E62-7BA2-4E90-8064-9357C964499CQ49241295-77D91F80-49FE-4829-B27F-3DB46F377643Q52584181-6FCA65B8-0E68-4591-A1CD-C83BDBCA3057Q53178938-D98A94E4-E86F-47FA-BACD-97C4F21CFBE9
P2860
Pharmacosynthetics: Reimagining the pharmacogenetic approach
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@ast
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@en
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@nl
type
label
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@ast
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@en
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@nl
prefLabel
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@ast
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@en
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@nl
P2860
P1433
P1476
Pharmacosynthetics: Reimagining the pharmacogenetic approach
@en
P2093
Bryan L Roth
Martilias S Farrell
P2860
P356
10.1016/J.BRAINRES.2012.09.043
P407
P577
2013-05-20T00:00:00Z